Share This

Related Topics News -

     
 Title only   |   Print 
     
翰森製藥與荃信生物-B簽訂QX004N對外授權協議 首付款7,500萬人幣

2024-04-25T  
醫藥股普遍造好 藥明系揚6%-8% 科倫博泰漲逾7%創上市新高

2024-03-25T  
《新股表現》荃信生物收24.5元高上市價23.7% 每手賬面賺940元

2024-03-20T  
《新股表現》荃信生物半日收26.15元 高上市價32%

2024-03-20T  
《新股表現》荃信生物-B高開逾38%報27.4元

2024-03-20T  
《新股消息》荃信生物獲162倍超購 一手中籤率5%

2024-03-20T  
《新股表現》荃信生物-B暗盤收27.35元高上市價38.1% 每手賬面賺1,510元

2024-03-19T  
《新股表現》荃信生物-B暗盤現報26.9元 高上市價近36%

2024-03-19T  
《新股消息》荃信生物-B今起招股 一手入場費4,081元

2024-03-12T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.